C3G

Clinical trials for C3G explained in plain language.

Never miss a new study

Get alerted when new C3G trials appear

Sign up with your email to follow new studies for C3G, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Drug trial halted after testing for rare kidney conditions

Disease control Terminated

This study tested an experimental drug called OMS721 (narsoplimab) in adults with four serious kidney diseases. The main goals were to check the drug's safety and see if it could reduce harmful protein in the urine, a key sign of kidney damage. The trial was terminated early and …

Matched conditions: C3G

Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

C3G

Get alerted when new C3G trials appear

Drug trial halted after testing for rare kidney conditions